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Abstract 
Background: The potential for a compound to cause hepatotoxicity and nephrotoxicity is a matter of extreme inter-
est for human health risk assessment. To assess liver and kidney toxicity, repeated-dose toxicity (RDT) studies are con-
ducted mainly on rodents. However, these tests are expensive, time-consuming and require large numbers of animals. 
For early toxicity screening, in silico models can be applied, reducing the costs, time and animals used. Among in 
silico approaches, structure–activity relationship (SAR) methods, based on the identification of chemical substructures 
(structural alerts, SAs) related to a particular activity (toxicity), are widely employed.
Results: We identified and evaluated some SAs related to liver and kidney toxicity, using RDT data on rats taken from 
the hazard evaluation support system (HESS) database. We considered only SAs that gave the best percentages of 
true positives (TP).
Conclusions: It was not possible to assign an unambiguous mode of action for all the SAs, but a mechanistic expla-
nation is provided for some of them. Such achievements may help in the early identification of liver and renal toxicity 
of substances.
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Background
Early identification of the potential for substances to 
cause hepatotoxicity and nephrotoxicity is of the utmost 
importance for human health risk assessment [1]. The 
liver is often involved in chemically-induced injuries and 
several factors actively contribute to the liver’s suscepti-
bility. Since most xenobiotics enter the body orally, are 
absorbed through the gastrointestinal tract and then are 
transported to the liver, this organ is the most exposed 
to their attack [2, 3]. The second reason is that the bio-
transformation of chemicals in the body takes place in 
the liver itself [4]. Most of time, biotransformation leads 
to the formation of a molecule that is no longer- or, at 
least, less-biologically active, more polar and water-solu-
ble hence more easily excreted from the body; however 
in some cases the metabolic activity of the liver produces 
toxic reactive chemicals [5].
Microsomal cytochrome P450 monooxygenases 
(CYP450) are important in the metabolism of several 
xenobiotics [6]. The liver is the organ with the richest 
source of P450s and other enzymes, but P450s are also 
expressed in various extra-hepatic tissues [7]. P450s are 
expressed in kidney mainly in the renal proximal tubule, 
which is also the primary target for xenobiotic-induced 
renal toxicity [8, 9]. Indeed, the biotransformation of 
chemicals into reactive metabolites is a key event for 
nephrotoxicity. The nephrotoxic metabolites may be pro-
duced locally by the action of P450s in the kidney or they 
can be produced in the liver or in other organs and trans-
ported into the kidney through the systemic circulation 
[10]. The high renal blood flow and the heavy concentra-
tions of excretory products, deriving from the re-absorp-
tion of water from the tubular fluid, are further important 
factors in the kidney’s susceptibility to xenobiotics [11].
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Since early evaluation of the potential risk to humans 
is not possible in humans, in  vivo repeated-dose toxic-
ity (RDT) studies are run in rodents [12–14]. One of the 
main aims of RDT is to define the no observed adverse 
effect level (NOAEL) and the lowest observed adverse 
effect level (LOAEL); these parameters indicate respec-
tively the dosage at which there is no significant response 
and lowest dosage at which adverse effects arise, com-
pared to a control group [15].
Some current legislations require the reduction of 
in  vivo studies when possible. These include the Euro-
pean Community (EC) Regulation No 1907/2006 (Reg-
istration, Evaluation, Authorisation and restriction of 
Chemicals, REACH) [16]. In other cases, experiments on 
animals are already banned, such as by Cosmetic Direc-
tive 76/768/EEC [17].
From the regulatory point of view, no alternatives to 
animal testing are currently acceptable for the assess-
ment of RDT. However, several attempts to assess 
in  vitro target-organ toxicities have been reported 
[13]. As a further alternative to animal testing, in silico 
approaches, such as structure–activity relationship 
(SAR) can help in prioritizing laboratory tests, preclini-
cal and clinical studies [18, 19]. The identification of 
structural alerts (SAs) which are chemical substructures 
whose presence may be related to the ability of a sub-
stance to cause adverse effects to organs, has met with 
some success. Such approach, alongside in vitro models, 
is effective for screening purposes [1]. Beside the statisti-
cal aspects related to in silico models, in the last decade 
the concept of mode of action (MoA) has been intro-
duced referring to a series of key biological events from 
the initial interaction of chemicals with biological sys-
tems to the adverse outcome, and now it plays a key role 
in predictive toxicology [20]. These mechanistic details 
can be employed as a basis for generating SAR or as a 
support of them.
In the last years, some research groups have suc-
cessfully developed SAs or chemical classes for iden-
tifying hazardous substances for liver and kidney [15, 
21]. Machine learning methods such as multiple linear 
regression (MLR) [22–24], linear discriminant analysis 
(LDA) [23], partial least square (PLS) [22] and k-nearest 
neighbors (k-NN) [25, 26] have been applied for the pre-
diction of RDT. Unlike SAs based strategies, that enables 
toxicity predictions on the basis of a qualitative repre-
sentation of chemical structures (SAR), such methods 
employ numerical representations of chemicals for the 
derivation of predictive models (quantitative structure–
activity relationship, QSAR,). For the ease of example, 
molecular descriptors [27] and fingerprints [28, 29] are 
widely used methods that enable quantitative representa-
tion of chemical structures.
Some software (mostly commercial) and literature 
models have been developed for predicting liver and 
renal injury [30]. However, consistent and reliable data 
for obtaining accurate models are still scarce and thus 
developing predictive systems for systemic toxicity still 
remains an open challenge [31].
This work proposes some SAs related to liver and renal 
toxicity, using RDT data on rats, which may be useful for 
the early evaluation of toxicity of substances. These rules 
will be implemented into the ToxRead software [32], a 
new freely available tool that assists users in read-across 
approach.
Results and discussion
To consider SAs with good ability to predict the toxic-
ity under investigation, we selected only SAs with a like-
lihood ratio (LR) of two or more and with at least 70 % 
true positive (TP). However, when where was only a very 
small number of total occurrences (three) we decided to 
retain only those rules that gave 100 % TP.
We report the SAs identified for liver and kidney tox-
icity. We could not always assign an unambiguous mode 
of action (MoA) for all the fragments. However, in some 
cases we provided a plausible mechanistic explanation, 
which was confirmed and supported by examples avail-
able in literature. It is important to keep in mind that 
the data available to derive these rules are limited, thus 
sometimes there are very few occurrences.
The SAs are encoded as SMiles Arbitrary Target Speci-
fication (SMARTS) that is a language used for specifying 
substructures using rules that are extensions of simplified 
molecular input line entry specification (SMILES) nota-
tion including, for instance, wildcards characters and for 
describing the chemical structure in a more general way 
[33].
Structural alerts for liver toxicity
Table  1 reports the complete list of SAs for liver toxic-
ity with their statistical performance. Out of the nine SAs 
found, four had 100 % TP. In the other cases the TP % was 
lower; however the number of occurrences was higher.
The SA having ID  =  3 is 1,2,4,5-tetrachlorobenzene, 
it was found four times in our dataset and it always 
matched experimentally-hepatotoxic compounds, so 
there was 100  % TP. The chlorobenzenes are important 
environmental contaminants employed for several pri-
vate and industrial applications [34]. They are hepato-
toxic in rodents and mice after repeated exposure [35]. In 
particular, 1,2,4,5-tetrachlorobenzene is a hepatic carcin-
ogen that promotes glutathione S-transferase (GSTP1-
1)-positive pre-neoplastic foci in rat liver [34].
The toxicological pathway shared by many haloben-
zenes is suggested by Sakuratani et  al. [15] and Greim 
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[35]. Briefly, halobenzenes are metabolically activated 
by cytochrome P450, which transforms them into epox-
ides, highly reactive electrophilic species. The sponta-
neous conversion of the epoxide to phenol and then the 
secondary oxidation of phenols by CYP450 enzymes 
lead to the formation of hydroquinones, which can be 
subsequently oxidized to quinones. Quinones too are 
electrophilic and can bind tissue proteins or lead to the 
Table 1 SAs recognized as harmful for liver
ID SMARTS Structure LR occurrences No TP TP%
1 Cc1c(c(ccc1)C(C)) inf 7 7 100
2 C(C(COC)CC) inf 7 7 100
3 c1c(c(c(c(c1Cl)Cl))Cl)Cl inf 4 4 100
4 C(CO)Cl inf 3 3 100
5 c1cc2ccccc2cc1 5.61 8 7 87.5
6 c1c(c(cc(c1)CC))[OH] 8.02 11 9 81.8
7 c1cc(ccc1Cc2ccc(cc2)) 4.28 19 16 84.2
8 c1ccc(cc1)c2ccccc2 2.4 8 6 75
9 CBr 2.4 8 6 75
For each structure the percentage of likelihood ratio (LR) as calculated by SARpy, the total number of occurrences and percentage of true positives (TP %) are 
reported. Marvin Sketch was used for drawing the structures
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generation of reactive oxygen species harmful for hepatic 
cells [15, 25] (Fig. 1).
The SA having ID = 5 reports the naphthalene ring, a 
polycyclic aromatic hydrocarbon, known as an environ-
mental contaminant, and classified as a potential human 
carcinogen [36]. It is widely used commercially in the 
synthesis of dyes, resins, plastics, pharmaceuticals, dis-
persants and tanning agents in the rubber and leather 
industries [36, 37]. In humans and laboratory animals, 
the eyes and lungs are the organs mostly involved after 
exposure to naphthalene [38]. However, naphthalene is 
also implicated in hepatocyte injury and liver dysfunc-
tion [37]. Indeed, early studies demonstrated that it 
caused lipid peroxidation in liver as well as increasing 
liver weight and aniline hydroxyalase activity [39–41]. 
In in vitro and in vivo models, metabolism of naphtha-
lene is a key event in its toxicity [36]. Its main metabolic 
pathways in mammals are described in Fig.  2. Once 
absorbed, naphthalene can be metabolized by various 
CYP 450 [42]. Briefly, CYP450 converts naphthalene into 
naphthalene epoxide, which can undergo several reac-
tions: conjugation to glutathione (GSH), transformation 
into naphthol or into dihydrodiol. Naphthol and dihy-
drodiol are both enzymatically converted to naphtha-
lenediol, which is further oxidized to naphthoquinone 
through redox cycling; this final reaction generates reac-
tive oxygen species (ROS). ROS induce oxidative stress, 
leading to cell death. In addition, quinones can form 
adducts with proteins or DNA, leading to cell damage 
[36, 42].
The SA having ID = 6 is the para-alkyl phenol. It was 
found 11 times in the dataset. In nine cases it was found 
in molecules labelled as hepatotoxic. Phenols, commonly 
present in the environment, are substances largely used 
in chemical and pharmaceutical industry [43]. The key 
event that leads to phenol toxicity is its interaction with 
cell biomolecules combined with the donation of free 
electrons from oxidized substrates [43]. The main effect 
of these reactions, catalyzed by oxidative enzymes in the 
liver, is the formation of phenoxy radicals, semiquinones 
and quinine methide that, finally, bind and damage DNA 
or enzymes. As a consequence of these reactions, ROS 
such as superoxide radicals and hydrogen peroxide, are 
also created [43]. Phenolic compounds with ortho- or 
para-alkyl groups (alkylphenols) can also form quinone 
methides that interact with biomolecules in the cell [44].
The SA having ID = 8 is the biphenyl. It occurred eight 
times in the datasets and in six cases it was correctly 
associated with hepatotoxic compounds. Several in vivo 
studies on rodents reported liver toxicity, including his-
topathological changes and increases in liver weight and 
serum liver enzymes after exposure to this chemical 
[45–47]. However, only few human data are available for 
biphenyl and these are even limited to two occupational 
epidemiology studies involving workers handling this 
chemical [48, 49]. These studies provided some evidence 
of liver toxicity, such as increases of serum enzyme levels.
The last SA selected is bromomethane reported with 
ID = 9. It was found eight times in the dataset and in six 
cases it was correctly associated with compounds labelled 
Fig. 1 Metabolic hepatic pathway of halobenzenes mediated by CYP450. X stands for any halogenated atom
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as hepatotoxic. A previous study [50] reported that rats 
exposed through inhalation to bromomethane showed 
histopathological changes and hepatocellular degenera-
tion, such as foci of hepatocellular coagulative necrosis. 
However, no mechanism of action of this compound on 
liver tissue is reported in the literature.
It was not possible to find a mechanistic explanation in 
the literature for SAs having ID 1, 2, 4 and 7; however, the 
percentage of TP was high for these substructures. SAs 1, 
2 and 4 had 100 % TP and SA 7 84.2 % TP.
Structural alerts for renal and urinary tract toxicity
Table 2 gives the complete list of SAs identified for renal 
and urinary tract toxicity with their statistical perfor-
mance. The fragments give 100 % TP except for the last 
SA (ID = 6), which has 71.4 % TP since there were two 
errors.
The second SA (ID = 2) found for renal toxicity is sul-
fanilamide. It was found four times into our dataset with 
100 % TP. The LR, calculated by SARpy software [51], is 
infinite. Sulfanilamide belongs to the chemical class of 
sulfonamides which are antibiotics widely used for the 
treatment of bacterial and protozoa infections in veteri-
nary and human medicine [52, 53]. The literature for this 
chemical category indicated that their relatively insolubil-
ity in acid urine means these compounds can precipitate 
in the tubular lumen forming insoluble crystals, leading 
to hematuria, albuminuria, crystalluria, renal colic and 
even acute renal insufficiency [54, 55]. Acid urine and 
dehydration promote sulfonamide crystallization [55] 
(Fig. 3).
Benzonitriles (SA, ID  =  3) are solvents with many 
industrial applications. Bromoxynil, chloroxynil, 
dichlobenil, and ioxynil are chemically similar pesticides 
that share the same benzonitrile structure [56]. A recent 
investigation [57] reported that the benzonitriles had 
adverse effects in  vitro on the human embryonic renal 
cell line HEK293T, with significant cytotoxicity.
SA having ID =  5 is the chloroform structure. It was 
found three times, in all cases in molecules related to 
kidney toxicity. Chloroform is used as a solvent in many 
industrial applications [10]. It causes renal toxicity in 
Fig. 2 Partial metabolic pathways of naphthalene in mammalians
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several species through a P450-dependent metabolism 
that leads to the formation of nephrotoxic chloroform 
metabolites [58, 59]. It has been reported that chloroform 
induces renal cancer, not via direct DNA reactivity, but 
for events associated with cytolethality and regenerative 
cell proliferation caused by exposure to chloroform [60, 
61]. Regenerative cell proliferation is an important part 
of the repair process and this mechanism has been posi-
tively linked to the carcinogenicity of some non-geno-
toxic chemicals in animal bioassays [10].
The last SA, having ID = 6, found for renal and urinary 
tract toxicity was biphenyl. This fragment was identified 
Table 2 SAs recognized as harmful for kidney and urinary tract
ID SMARTS Structure LR occurrences No. TP TP%
1 c1ccc(cc1)S(=O)(=O)O inf 4 4 100
2 NS(=O)(=O)c1ccc(cc1)N inf 4 4 100
3 c1cc(cc(c1)C#N) inf 3 3 100
4 CC(=CCCC(=C)) inf 3 3 100
5 C(Cl)(Cl)Cl inf 3 3 100
6 c1ccc(cc1)c2ccccc2 3.3 7 5 71.4
For each structure the percentage of likelihood ratio (LR) as calculated by SARpy, the total number of occurrences and percentage of true positives (TP %) are 
reported. Marvin Sketch was used for drawing the structures
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seven times and in five cases the molecules were actu-
ally labelled as nephrotoxic. A large number of studies 
on animals have reported the toxicological role of biphe-
nyl in serious injury of the urinary tract [45, 62–65]. 
The effects on animals were hematuria, increased uri-
nary pH, increased kidney weight, formation of calculi 
accompanied by the induction of urinary tract tumours. 
Potassium 4-hydroxy-biphenyl-O-sulfate is one of main 
biphenyl metabolites involved in the formation of urinary 
calculi, due to its low solubility. The presence of urine 
crystals, promoted by higher pH and potassium concen-
trations, is the first step in urinary calculi formation [65]. 
However, the mechanism that leads to the formation of 
the urine crystals induced by exposure to biphenyl still 
needs to be fully elucidated [65].
To the best of our knowledge a mechanistic explana-
tion for SAs having ID 1 and 4 was no available in the lit-
erature. The percentage of TP for both of them was 100.
Besides those we identified, other SAs were developed 
for liver and kidney toxicity [15, 21, 66]. Some of them are 
the same that we here reported. Similarly to our findings, 
Sakuratani et al. [15] identified halobenzenes (Table 1, SA 
ID =  3), para alkyl phenols (Table  1, SA ID =  6), halo-
genated aliphatic compounds (Table  1, SA ID =  9) and 
aromatic hydrocarbons (Table 1, SAs ID = 1, 5, 6, 7 and 
8) as alerts related to hepatotoxicity and sulphonamide 
group (Table 2, SA ID = 2) to urinary tract toxicity. Phe-
nols (Table 1, SA ID = 6) were identified as hepatotoxic 
by a recent study [21] that used a dataset of pharmaceu-
tical chemicals as starting point to identify SAs for liver 
toxicity.
The overlap of these results should not be interpreted 
as a redundancy of the findings, rather a confirmation 
of the data obtained. Indeed, the key point is that start-
ing from different sets of data and even applying differ-
ent methods, all these studies come to same results. This 
increases the reliability of the SAs for the prediction of 
toxicity.
Compared to hepatotoxicity, nephrotoxicity is less 
investigated from a computational point of view. The 
major contribution of this work is related to kidney tox-
icity since most of our results on liver toxicity confirm 
those previously obtained by other authors with the 
exception of SAs having ID 2 and 4.
Experimental
Selection of data
RDT data for modeling are present in the Hazard Eval-
uation Support System (HESS) database [15], which 
was downloaded from the OECD QSAR Toolbox [67]. 
This database provides NOAEL and LOAEL values and 
gives information on the organ toxicity for 503 chemi-
cals tested on rats by oral exposure over periods ranging 
from 28 to 120 days. More details on these data can be 
found in [15]. For the selection of the liver toxicity data 
to be used for modeling, we considered the compounds 
for which LOAEL related to effects on liver was reported 
and we labelled them as “active” substances. Those com-
pounds with reported LOAEL effects on organs other 
than liver were considered negative controls and were 
labelled as “inactive”. We applied the same procedure to 
build a dataset for renal toxicity.
We finally obtained two datasets: one containing 218 
liver toxicity data (121 of which were “active”) and the 
other with 202 data related to kidney toxicity (89 labelled 
as “active”). Some compounds appear in both datasets 
since at the LOAEL they reported effects both on liver 
and kidney. We labelled “active” the data that indicated 
liver or renal effects after 28 or 90 days of exposure and 
“inactive” those had no effect on the organ of interest 
after 90  days of exposure, since if no effect is reported 
after 28 days it may occur later (90 days) (Fig. 4). We con-
sidered only organic compounds; salts were neutralized 
and we double-checked the correspondence between 
CAS number and chemical structures using Pubchem 
compound [68] and ChemID plus [69]. For the dataset on 
Fig. 3 Toxicity pathway for sulfamides. Ar stands for aryl group, AH stands for any atoms including hydrogen
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nephrotoxicity, we also included compounds reported to 
have effects on the urinary tract.
Extraction and evaluation of structural alerts
In order to obtain SAs related to liver and kidney toxicity, 
we used the software SARpy, developed by Politecnico di 
Milano and described in Ferrari et al. [51]. Briefly, SARpy 
is able to extract sets of rules by automatically generating 
and selecting substructures on the sole basis of their pre-
diction performance on a training set used as input [51] 
and irrespective of any a priori knowledge. This is done 
in three steps. The first step is the fragmentation of the 
input chemicals (training set) in order to extract all the 
substructures within a customizable size range. Then, the 
software analyses the correlation between the occurrence 
of each molecular substructure and the experimental 
activity of the compounds that contain it in the training 
set. This is a validation step aimed at assessing the pre-
dictive power of each fragment. Finally, a subset of frag-
ments is selected and provided to the user in the form of 
rules ‘‘IF fragment THEN activity’’ [70]. The input and the 
output chemical structures of SARpy are all expressed as 
SMILES [33]. The statistical parameter used for defining 
the precision of a fragment to predict the activity under 
investigation is the LR, calculated for each SA as:
TP are experimentally positive (toxic) compounds cor-
rectly predicted as positive, false positives (FP) are exper-
imentally negative but wrongly predicted as positive. 







Fig. 4 Procedure for selecting data in the HESS database
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correctly predicted compounds out of the total number 
of occurrences.
SARpy can be customized so as to minimize the num-
ber of FP, or in a more balanced way, to improve the accu-
racy. We used SARpy with different settings (min, max, 
optimal) in order to get a large number of SAs, then each 
fragment was evaluated and those did not meet our cri-
teria were eliminated and not considered further. Indeed, 
we did not use SARpy like a black box, but we carefully 
checked every SA generated by the software and in some 
cases they were generalized so as to have rules to match 
correctly with a larger number of compounds.
Conclusions
Liver and kidney toxicities are key points in the evalu-
ation of safety for existing and new substances. Many 
in vivo RDT studies have been done to assess the ability 
of a chemical to induce hepatotoxicity and nephrotoxic-
ity. However, in many regulatory contexts, the tendency 
is to strongly reduce the number of in  vivo tests. Thus 
there is an urgent need for reliable alternatives to ani-
mal testing, in order to protect human health. In silico 
methods may be useful to minimize the number of ani-
mals required and to reduce time and costs. We have 
proposed some SAs that are chemical substructures that 
may be related to hepatotoxicity and nephrotoxicity. For 
some of them a mechanistic explanation is also provided 
as further evidence. The aim is not to fully replace in vivo 
studies, but to provide a supporting tool that may be used 
for early identification and prioritization of the potential 
toxicity of substances.
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